Aggregation of D-synuclein (D-SYN) plays a key role in Parkinson's disease (PD). We have used fluorescence correlation spectroscopy (FCS) to study D-SYN aggregation in vitro and discovered that this process is clearly accelerated by addition of FK506 binding proteins (FKBPs). This effect was observed both with E. coli SlyD FKBP and with human FKBP12 and was counteracted by FK506, a specific inhibitor of FKBP. The D-SYN aggregates formed in the presence of FKBP12 showed fibrillar morphology. The rotamase activity of FKBP apparently accelerates the folding and subsequent aggregation of D-SYN. Since FK506 and other nonimmunosuppressive FKBP inhibitors are known to display neuroregenerative and neuroprotective properties in disease models, the observed inhibition of rotamase activity and D-SYN aggregation, may explain their mode of action. Our results open perspectives for the treatment of PD with immunophilin ligands that inhibit a specific member of the FKBP family.
are eosinophilic cytoplasmic inclusions that are predominantly composed of aggregated D-SYN (2) . Second, point mutations in D-SYN have been discovered in three autosomal dominant familial forms of PD (3) (4) (5) . The mutant forms of D-SYN were shown to oligomerize faster than the wild-type (WT) form (6, 7) . More recently, locus duplication (8) or triplication (9) of the D-SYN gene was identified as another cause of familial PD, demonstrating the dose-dependency of the pathogenic D-SYN effect. Finally, overexpression of both WT and mutant forms of D-SYN in C. elegans, Drosophila, mice, or rats leads to neuronal inclusions and/or pathological symptoms very similar to those observed in PD (10) (11) (12) (13) (14) . Moreover, in these animal models it has been shown that the onset of pathology coincides with D-SYN aggregation.
Three regions can be recognized in the D-SYN protein. The N-terminal part (aa 1o 60) is characterized by nine imperfect repeats containing a conservative hexamer motif KTKEGV. These repeats contribute to the formation of an D-helical structure in the N terminus when D-SYN interacts with lipids (15) . The sequence of this region is strongly conserved throughout evolution. Moreover, all three clinical mutations are found in this region, which adds to the importance of this domain for the normal function of D-SYN. The central hydrophobic domain of D-SYN (aa 61o95), also known as the NAC domain (non AE-Component of amyloid plaques in Alzheimer's disease), is necessary and sufficient for the aggregating properties of D-SYN, since it was shown that a deletion of aa 71-82 in human D-SYN inhibits fibril formation in vitro (16) . Eand J-synuclein, two other proteins of the synuclein family that do not aggregate, lack this region, which confirms its importance for aggregation. The C terminus of D-SYN (aa 96o140) has a low hydrophobicity, contains many acid residues (10 Glu, 5 Asp) and the only 5 proline residues in the protein. This domain is the least conserved among the different proteins of the synuclein family. By combining a high net charge with a low hydrophobicity, this part is responsible for the low tendency of D-SYN to self-aggregate in solution. The aggregation of D-SYN is a nucleation dependent process with an initial lag phase, a propagation step, and a steady-state phase (17, 18) .
In this study, we demonstrate that the aggregation process is greatly accelerated in vitro, in the presence of FK506 binding proteins (FKBPs). FKBPs are members of the immunophilins, enzymes that bind to immunosuppressant drugs and have a peptidyl-prolyl isomerase (PPIase) or rotamase activity (19) . In unfolded proteins, X-proline dipeptides generally exist for ~80% in the cis conformation. In a folded protein, around 80% of X-proline bonds are in the trans conformation. The PPIase activity is believed to help the cis-to-trans conformational change, an energy-demanding (activation energy barrier of 80-100 kJ mol -1 ) and thus often rate-limiting step in protein folding. Other members of the immunophilins in humans are the cyclophilins and the parvulins. A well-known parvulin is Pin1, an enzyme that is believed to play a role in Alzheimer's disease (AD) (20) .
Members of the FKBP family in humans have many different activities [for a review see (19) ]. They have been categorized as chaperone or heat-shock proteins. FK506, a powerful immunosuppressant (21) , binds to all FKBPs and is a potent and specific inhibitor of their PPIase activity (22, 23) . Lately, some reports have ascribed neuroregenerative and neuroprotective properties to FK506 in cell culture and in vivo PD models (24, 25) . Two members of the FKBP family, FKBP12 and FKBP52, are known to be expressed in the SN and in the deep gray matter of the human brain (26) . Avramut et al. found that the expression of FKBP12 increased in the brain of patients with PD, AD and Dementia with Lewy Bodies and FKBP12 was found to colocalize with D-SYN in Lewy bodies and Lewy neurites (26) , suggesting a potential role in PD. In male rats, both FKBP12 and FKBP52 are up-regulated following transient focal ischemia (27) . Gold et al. propose FKBP52 as target for the neurotrophic activity of FK506 (28) .
We decided to investigate the aggregation process of D-SYN by fluorescence correlation spectroscopy. During purification of D-SYN, we identified the E. coli FKBP SlyD as an impurity that greatly accelerated D-SYN aggregation in vitro. The human counterpart FKBP12 was subsequently found to stimulate this aggregation as well. The proaggregatory effect was confirmed by turbidity, Thioflavine T measurements, and laser scanning microscopy.
MATERIALS AND METHODS

Construction of D-SYN expression plasmid and purification of D-SYN
The lentiviral vector transfer plasmid (pCHMWS) containing human D-SYN cDNA has been described before (29) . The D-SYN cDNA was cloned into pRSET B (Invitrogen, Carlsbad, CA), a prokaryotic expression vector that inserts an N-terminal His-tag in the recombinant protein.
DNA sequencing confirmed the correct sequence and reading frame.
BL21-T1 resistant E. coli cells (Stratagene, La Jolla, CA) were transfected with pRSET B containing the D-SYN cDNA. In the presence of 50 μg/mL carbenicillin (Sigma-Aldrich, St Louis, MO), transfected cells were grown to an 8 L culture at 37°C. At an OD of 0.8, cultures were induced with 1 mM IPTG and left to shake for another 3 h at 30°C. After harvesting, pellets were solubilized in 35 ml sonication buffer [20 mM Hepes (Sigma-Aldrich), 100 mM NaCl, 1 mM PMSF (Sigma-Aldrich), 0.05 mM EDTA (Chimica, Geel, Belgium), pH 7.4] and frozen overnight. The cells were disrupted by sonication. This cell lysate was heated to 65°C during 45 min and centrifuged again for 30 min at 4°C and 39100 g in a Sorvall® RC-24 Refrigerated Superspeed Centrifuge. The supernatant was filtered through a 22 μM filter (Millipore, Billerica, MA) and applied on a Protino Ni-TED affinity column (Macherey-Nagel, Düren, Germany). The column was washed with buffer containing 20 mM Hepes at pH 7.4, and 100 mM NaCl and eluted with the same buffer containing 250 mM imidazole. The protein fractions were analyzed with SDS-PAGE (4-12% Bis-Tris NuPage gels, Invitrogen). Fractions containing D-SYN were pooled and applied on a FPLC anionic exchange column (HiTrap QHP, Amersham Pharmacia, Uppsala, Sweden). The washing buffer contained 20 mM HEPES at pH 8, 100 mM NaCl, while the elution buffer was composed of 20 mM HEPES at pH 8 and 1 M NaCl,). Elution fractions containing protein were again analyzed on SDS-PAGE, and the protein fractions were pooled. Western blot analysis was performed with a rabbit anti-D-SYN polyclonal antibody (1:5000 Chemicon International, Inc., Temecula, CA) and a HRP-labeled goat anti rabbit antibody (DakoCytomation, Glostrup, Denmark) as secondary antibody. The pooled D-SYN was afterwards applied on a desalting column (HiPrep TM 26/10 Desalting, Amersham Pharmacia) washed with 20 mM ammonium bicarbonate. The peak fraction from this column was pooled, and the concentration of D-SYN was calculated after determining the OD at 276 nm (H=5800 M -1 cm -1 ). Aliquots containing 1 mg D-SYN were frozen overnight at -70°C and then lyophilized (Heto DRY WINNER model DW3, Heto Holten A/S, Allerød, Denmark). Typical yields were 30 mg from an 8 L culture.
FK506 and FKBP proteins
FK506 was purchased from Calbiochem (EMD Biosciences, San Diego, CA) Human recombinant GST-FKBP12 protein was a generous gift of Dr. G. Bultynck (30, 31) (Laboratory for Physiology, K.U.Leuven, Belgium). It has been shown that GST-FKBP12 retains it capacity to bind immunophilin ligands (32) and that the enzymatic activity is not altered by the fusion of GST (Bultynck, G.; article in press). Therefore, we used GST-FKBP12 in all experiments. We will further mention this protein as FKBP12.
Fluorescence correlation spectroscopy
To visualize the aggregation of D-SYN, fluorescence correlation spectroscopy (FCS) was used (33) (34) (35) (36) . Measurements were performed on the LSM 510/ConfoCor II combination (Zeiss, Jena, Germany). In FCS, the diffusion coefficient of a fluorescent molecule is calculated from the autocorrelation function of the fluctuating fluorescence signal, resulting from the diffusion of molecules through the confocal volume. The following autocorrelation function is calculated from the fluorescence fluctuation signal:
N is the mean number of molecules in the confocal volume, Z 1 and Z 2 are the radial dimensions at 1/e 2 of the maximal intensity of the Gaussian beam profile in the x-, y-, and z-directions, respectively. The half-point of the autocorrelation curve is the average time necessary for a fluorescent molecule to pass through the confocal volume and is called the diffusion time W d = Z 1 2 /4D; whereD is the translational diffusion coefficient of the fluorescent molecule.
Through the calibration with a fluorescent dye with known diffusion coefficient, the structure parameter (Z 2 /Z 1 ) can be determined. Depending on the shape of the molecule, the size of the molecule can then be calculated from the diffusion coefficient. Supposing a molecule with a globular shape, the radius of the molecule can be determined from the Stokes-Einstein relation:
Where k is Boltzmann's constant ( K J 23 10 38 . 1 ), T is the temperature in Kelvin, K is the viscosity of the solution, and r is the radius of the globular molecule.
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When two species with a different diffusion coefficient and a different brightness are present in solution, the autocorrelation function has to be rewritten:
with 1 y and y being the fraction of the molar concentration of the two fluorescent species, 1 W and 2 W their respective diffusion times and D the ratio of the brightness of species 2 to species 1.
In the experiments discussed below, the labeling reaction was not completely irreversible, causing free dye to be present in solution next to the D-SYN bound dye. Therefore, a twocomponent model was used with W 1, the diffusion time of the free dye and W 2 that of the dye bound to D-SYN. W 1 was measured separately and fixed in all fits. Because the counts per molecule of the free and bound dye were the same, D = 1.
Fluorescent labeling of proteins
To fluorescently label D-SYN, the point mutation S42C was introduced in the cDNA. Since For the fluorescent labeling of human FKBP12 we chose the dye Cy5, with an excitation wavelength of 633 nm (Amersham Biosciences), to avoid cross-talk between light emissions from labeled D-SYN and FKBP12. FKBP12 was stirred in a dark tube at room temperature for 2 h with Cy5 NHS-ester. To separate unreacted free dye from labeled protein, the sample was applied on a PD10 desalting column (Amersham Pharmacia).
FCS measurements
In each FCS experiment the ratio of non-labeled WT D-SYN vs labeled S42C D-SYN was ~1000:1. Before each experiment, all pre-existing aggregates were removed from the sample by increasing the pH to 11 for 10 min with NaOH to dissolve small oligomers and, immediately after lowering the pH again to 7.4 with HCl, a subsequent centrifugation step (10 min at 13 400 rpm in a tabletop centrifuge) to remove the larger aggregates (37) . Samples were then incubated at 37°C under continuous stirring. For 
J 0 is the value of the diffusion time at time 0, reflecting the diffusion time of monomeric D-SYN, W 0 is the half-time of the aggregation and is influenced primarily by the nucleation process, a is the difference in diffusion time before and after aggregation and k is the observed rate constant of approach to the final steady state.
Visualization of fluorescent aggregates
After each FCS measurement, a confocal image of the bottom of the glass slide was taken using the laser scanning microscope (LSM 510) coupled to the ConfoCor II. Thanks to the incorporation of fluorescent S42C D-SYN molecules, large aggregates that precipitated to the bottom of the slide became visible, and their size and shape could be determined. We could control for the completeness of this precipitation via the FCS measurement. Bright fluorescence spikes, which occur when large aggregates containing multiple labeled D-SYN molecules diffuse through the confocal volume disappear toward the end of each measurement (~7 min), confirming their precipitation.
Turbidity measurements
Sample preparation was the same as for the FCS measurements, with the exception that no fluorescent D-SYN was added. At each time point, the turbidity of a 70 μl sample was determined at 350 nm (UV-1650PC UV-visible spectrophotometer, Shimadzu, BB 's-Hertogenbosch, the Netherlands). After the measurement, the 70 μL was returned to its original 250 μL solution at 37°C. The time-dependent curve was fitted to a sigmoid curve with four parameters as described above (Eq. 5).
Transmission electron microscopy
Samples were adsorbed (for 5 min) to a 300-mesh carbon-coated copper formvar-grids and negatively stained with 1% uranyl acetate for 2 min. The samples were examined with a Zeiss EM 10C electron microscope operating at 60 keV.
RESULTS
An E. coli FKBP co-purifies with D-SYN
Human recombinant D-SYN with N-terminal His-tag was expressed in E. coli and purified using a heat-shock, followed by affinity chromatography (Fig. 1) . Western blotting confirmed that the prominent band at ~20 kDa corresponded with D-SYN. Higher-molecular-weight aggregates of D-SYN were also detected on Western blot. Apart from D-SYN, a protein of ~26 kDa was consistently revealed by SDS-PAGE but was not recognized by antibodies against D-SYN in the Western blot (Fig. 1A, B) . Mass-spectrometry analysis allowed unambiguous identification of this impurity as E. coli FKBP-type peptidyl-prolyl cis-trans isomerase slyD. This enzyme is heat stable and rich in histidines, explaining its co-purification. With anion exchange chromatography we could remove the impurity from the D -SYN preparation (Fig. 1C ).
Aggregation of purified recombinant D-SYN can be measured by FCS
To verify the aggregating properties of purified His-tagged D-SYN, an aggregation test was performed in the presence of spermine, a polycation known to enhance the aggregation rate of D-SYN. Normally, electric repulsion between negatively charged D-SYN molecules inhibits the formation of fibrils in vitro. Spermine promotes the association of D-SYN molecules through the shielding of the negative charges in the C terminus (38) . In the FCS measurements, the diffusion coefficient of monomeric D-SYN was calculated to be (5.8±0.65) • 10 -11 m 2 /s (n=6). Assuming a spherical shape of the molecule, the radius of D-SYN was estimated from Eq. 3 to be 4.3 ± 0.5 nm, which is comparable with the radius of gyration of 4.0 ± 0.1 nm determined before by small angle X-ray scattering (41) . At the end of the FCS measurements, the diffusion time of D-SYN oligomers is generally 2 to 3 times larger than in the beginning of the measurement, suggesting that these aggregation intermediates are 2 3 or 3 3 times larger than the monomers (assuming spherical symmetry). The very large aggregates give rise to fluorescent spikes, which cannot be analyzed by FCS (see Discussion).
E. coli PPIase SlyD enhances the aggregation rate of D-SYN in vitro
FCS experiments with the different D-SYN protein preparations revealed that D-SYN with the E. coli PPIase present as a contamination aggregated within 8 h, in contrast to pure D-SYN that did not show any increase in diffusion time during this time interval (data not shown). Therefore we decided to purify the PPIase following the same protocol as for the purification of D-SYN using non-transformed E. coli cells. Addition of 6 nM purified SlyD to 70 μM of D-SYN drastically increased the aggregation rate of D-SYN while addition of 6 nM ovalbumine had no effect ( Fig.  2A) . To determine the specificity of the stimulatory effect of SlyD on the aggregation rate of D-SYN, FK506, a well-known inhibitor of PPIase activity, was added to the reaction mixture (Fig.  2B) . FK506 inhibited D-SYN aggregate formation in the presence of SlyD in a dose-dependent way. The inhibition was complete at a sevenfold molar excess of FK506 to SlyD.
Human FKBP12 enhances the aggregation rate of D-SYN
To determine the potential physiological relevance of our findings, we decided to analyze the effect of human FKBP12 on D-SYN aggregation. The same experimental setup was followed as for the FCS aggregation assay with the E. coli PPIase. First, D-SYN was incubated with different concentrations of FKBP12 (Fig. 3A) . Similar to the bacterial PPIase, human FKBP12 stimulated D-SYN aggregation in a dose-dependent way. To follow the aggregation process until completion, we also performed turbidity measurements, a validated method for measuring D-SYN aggregation. As shown in Fig. 3B , the results of the turbidity measurement confirmed the FCS data. The half-time of the aggregation of D-SYN in the presence of 250 μM spermine (120 min) matches that of the previous FCS measurement in similar conditions (123 min; Fig. 2A ), suggesting that FCS and turbidity follow the aggregation of D-SYN in vitro in a similar time window and that oligomer formation is rate limiting for polymerization. Also in Thioflavin T fluorescence measurements FKBP12 was found to stimulate aggregation of D-SYN (data not shown).
Again, the specificity of the pro-aggregatory effect of FKBP12 on D-SYN was verified by addition of the inhibitor FK506. This slowed down the aggregation process in a dose-dependent way (Fig. 3C ). The effect of FKBP12 was completely abolished at 120 PM FK506. In these experiments 60 μM of spermine was added to all samples to accelerate the aggregation process.
FKBP12 stimulates D-SYN fibril formation
Since the D-SYN aggregates found in LBs are predominantly fibrillar, we investigated the nature of the D-SYN aggregates in closer detail. After each FCS measurement, a laser scanning confocal image of the bottom of the glass slide was taken, which allowed visualization of large aggregates that had precipitated to the bottom of the slide (Fig. 4) . The D-SYN aggregates formed upon incubation with FKBP12 predominantly had a fibrillar appearance (Fig. 4A, B , E, and F), while some of them displayed a twisted morphology (Fig. 4G, H) . Twisted filaments of D-SYN have previously been encountered in Lewy bodies (42) , suggesting that the aggregates formed in the presence of FKBP12 can be physiologically relevant. The presence of fibrillar D-SYN aggregates upon incubation with FKBP12 was also confirmed with transmission electron microscopy ( Fig. 5 ). When incubated with spermine, D-SYN first formed fibrillar-like aggregates, which condensed afterwards in amorphous aggregates (Fig. 4C, D) . This effect of spermine on the morphology of D-SYN aggregates has been described before (43) .
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FKBP12 does not co-aggregate with D-SYN
The accelerated aggregation of D-SYN by nanomolar concentrations of SlyD or FKBP12 strongly supports a catalytic role for FKBPs in this process. Alternatively, FKBP may accelerate the aggregation of D-SYN through stable binding of FKBP to D-SYN. To examine whether FKBP12 can bind to D-SYN FCS measurements were performed with D-SYN and FKBP12, each fluorescently labeled with a distinct fluorophore (Fig. 6 ). The diffusion time of FKBP12 remained constant during the increase in diffusion time of D-SYN. Moreover, fluorescent FKBP could not be detected in precipitated D-SYN-aggregates (data not shown).
DISCUSSION
Our work clearly demonstrates that proteins of the FKBP family accelerate D-SYN aggregation in vitro. Two members of this family have been investigated in detail, the E. coli FKBP-type peptidyl-prolyl cis-trans isomerase slyD and the human FKBP12. The two proteins are only distantly related (20.6% amino acid sequence identity) with the exception of the residues close to Asp 37 (44, 45) and Phe 99 (46, 47) , the two amino acids that have previously been shown to have the greatest effect on FK506 binding capacity and PPIase activity. Since both proteins exert a similar effect on D-SYN aggregation, it is possible that the evolutionary conserved PPIase activity of FKBP is responsible rather than other described functions. The inhibition of the effect of FKBP on the aggregation of D-SYN by FK506, an inhibitor of PPIase activity, also supports this hypothesis as does the fact that substoichiometric amounts of FKBP are sufficient to have a substantial effect on D-SYN aggregation. D-SYN contains 5 prolines (P108, P117, P120, P128, P138), all of which are located in the C-terminal end of the protein. This part is accepted to maintain the protein in an unfolded state in solution due to the high charge and low hydrophobicity (48) . When those properties are altered, e.g., by lowering the charge, aggregation of D-SYN is greatly enhanced (49) . Since we could not detect FKBP in the oligomers nor in the fibrils, our data strongly suggest that the enzymatic activity of FKBP is responsible for the accelerated aggregation of D-SYN We propose that, through facilitating the cis to trans isomerization of the prolines in the C terminus of D-SYN, the protein can rapidly adopt a partially folded conformation, suggested before as a key step in D-SYN aggregation (50, 51) . This implies that (mis)folding of D-SYN can initiate the aggregation of the protein (52, 53) . It might seem contradictory that a chaperone protein (in this case FKBP) induces abnormal aggregation of D-SYN. A similar example though was given by Uversky et. al. (54) , who showed that trimethylamine-N-oxide induces secondary structure formation and aggregation of D-SYN (55) although trimethylamine-N-oxide is a naturally occurring osmolyte that can assist thermodynamically unstable proteins in folding and regaining functional activity (56) .
We present a novel FCS-based approach to study D-SYN aggregation with multiple advantages. Using FCS, the effect of FKBP on D-SYN aggregation was observed at lower concentrations of FKBP than in turbidity measurements proving that FCS is a more sensitive technique in detecting small D-SYN aggregates than turbidity. Second, inhibitors or accelerators of D-SYN aggregation can be identified as well as interaction between D-SYN and other proteins. Finally, FCS automation allows high throughput evaluation of compound libraries in the search of novel inhibitors of D-SYN aggregation. On the other hand, FCS is only suited to follow the initial steps in the aggregation process. Upon formation of large aggregates, the chance of having only one or two fluorescent D-SYN molecules in the aggregate (a prerequisite of avoiding the occurrence of fluorescence spikes) is virtually inexistent. The largest aggregates with correspondingly the largest diffusion time are therefore always seen as fluorescent spikes. It is impossible to derive a correct autocorrelation function from those fluorescent spikes and therefore, their diffusion time cannot be extracted.
The effects of immunophilin ligands on neurodegenerative diseases have been studied before (26, (57) (58) (59) , although the exact mechanism has not been elucidated. Here we propose that immunophilin ligands can act through the inhibition of the accelerating effect of FKBP proteins on the aggregation of D-SYN. With this knowledge, novel drugs may be developed with a higher specificity toward relevant FKBP proteins. We do not yet know which FKBP may be involved in D-SYN aggregation in vivo. Currently, two FKBPs are known to be present in the substantia nigra: FKBP12 and FKBP52. It has been shown that the expression of those proteins changes in pathological conditions (60) . Moreover, FK506 was proposed to exert its neuroregenerative properties via FKBP52 (61) . Although in vitro, FKBP52 seems to have a smaller effect on D-SYN aggregation than FKBP12 (unpublished observations), the in vivo effect on D-SYN aggregation might be different because, in the cell, localization and concentration are often limiting factors. A possible link between FKBPs and PD might result from an increase in expression or redistribution of chaperone proteins in stress conditions. In the case of FKBP chaperones, this may be not beneficial as it leads to a decrease in the lag time of aggregation of D-SYN which may accelerate the onset of PD. Alternatively, D-SYN aggregation and accumulation into Lewy bodies may provide the cell with a defense mechanism against toxicity associated with D-SYN derivatives. Indeed, the cytotoxic vs protective role of D-SYN inclusions is still under intense debate (62) . In this case FKBP would rather protect against synucleinopathy and PD. Future experiments are needed to investigate whether the aggregation-inducing role of FKBP can be demonstrated in cell culture and animal models and to identify the aggregateinducing FKBP. 3 . The aggregation of α-SYN is influenced by human FKBP12 and its inhibitor FK506. A) Aggregation of 70 μM of α-SYN was followed over time by FCS in the presence of 30 nM, 120 nM, or 1.2 μM FKBP12. B) α-SYN (70 μM) was incubated with 250 μM spermine and 320 nM or 15 μM FKBP12. The absorbance of this mixture at 350 nm was followed in time. C) The aggregation of 70 μM α-SYN was followed by turbidity measurement in the presence of 500 nM FKBP12 and 12 or 120 μM of FK506. To accelerate the aggregation process, 60 μM of spermine was added to each sample. The lines are least-squares fits to the data points using equation (5) . 
